Nikesh Lifescience Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.12 M
- Paid Up Capital ₹ 0.12 M
- Company Age 3 Year, 7 Months
About Nikesh Lifescience Pharma
Nikesh Lifescience Pharma Private Limited (NLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 July 2021 (Three years and seven months 4 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.12 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Swapnil Bangad, Pankaj Gandhi, Ronak Zawar, and Three other members serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231PN2021PTC202426
-
Company No.
202426
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jul 2021
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Nikesh Lifescience Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Gandhi
|
Director | 07-Jul-2021 | Current |
|
Swapnil Bangad
|
Director | 07-Jul-2021 | Current |
|
Ronak Zawar
|
Director | 07-Jul-2021 | Current |
|
Abhishek Zawar
|
Director | 07-Jul-2021 | Current |
|
Nilesh Zawar
|
Director | 07-Jul-2021 | Current |
|
Venkatesh Bhutada
|
Director | 07-Jul-2021 | Current |
Financial Performance of Nikesh Lifescience Pharma.
Enhance accessibility to Nikesh Lifescience Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nikesh Lifescience Pharma?
Unlock access to Nikesh Lifescience Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nikesh Lifescience Pharma?
Nikesh Lifescience Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nikesh Lifescience Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nikesh Lifescience Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.